Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pexidartinib versus placebo for advanced tenosynovial gia... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
0
Authors
William Tap
22 more
William Tap
•
Hans Gelderblom
20 more
•
Andrew Wagner
Published
June 19, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Physics
Pathology
Medicine
Internal Medicine
Surgery
Show all topics
DOI
10.1016/s0140-6736(19)30764-0
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Physics
Pathology
Medicine
Internal Medicine
Surgery
Show all topics
DOI
10.1016/s0140-6736(19)30764-0
Other Formats
PDF
